Patrick  Lockwood-Taylor net worth and biography

Patrick Lockwood-Taylor Biography and Net Worth

CEO of Perrigo
Patrick Lockwood-Taylor was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective June 30, 2023. He joined Perrigo from Bayer AG, where he was Regional President of Consumer Health North America, while also serving a dual role as President of Bayer U.S. Before Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions.

What is Patrick Lockwood-Taylor's net worth?

The estimated net worth of Patrick Lockwood-Taylor is at least $550,527.50 as of February 29th, 2024. Mr. Lockwood-Taylor owns 20,500 shares of Perrigo stock worth more than $550,528 as of June 15th. This net worth approximation does not reflect any other investments that Mr. Lockwood-Taylor may own. Learn More about Patrick Lockwood-Taylor's net worth.

How do I contact Patrick Lockwood-Taylor?

The corporate mailing address for Mr. Lockwood-Taylor and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Patrick Lockwood-Taylor's contact information.

Has Patrick Lockwood-Taylor been buying or selling shares of Perrigo?

Patrick Lockwood-Taylor has not been actively trading shares of Perrigo over the course of the past ninety days. Most recently, on Thursday, February 29th, Patrick Lockwood-Taylor bought 9,500 shares of Perrigo stock. The stock was acquired at an average cost of $26.54 per share, with a total value of $252,130.00. Following the completion of the transaction, the chief executive officer now directly owns 20,500 shares of the company's stock, valued at $544,070. Learn More on Patrick Lockwood-Taylor's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 8 times. They purchased a total of 42,580 shares worth more than $1,199,876.50. The most recent insider tranaction occured on May, 28th when EVP Svend Andersen bought 1,000 shares worth more than $27,900.00. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 5/28/2024.

Patrick Lockwood-Taylor Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024Buy9,500$26.54$252,130.0020,500View SEC Filing Icon  
11/14/2023Buy11,000$28.99$318,890.0011,000View SEC Filing Icon  
See Full Table

Patrick Lockwood-Taylor Buying and Selling Activity at Perrigo

This chart shows Patrick Lockwood-Taylor's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $26.86
Low: $26.59
High: $27.36

50 Day Range

MA: $29.88
Low: $26.39
High: $33.43

2 Week Range

Now: $26.86
Low: $25.77
High: $40.28

Volume

1,461,795 shs

Average Volume

1,705,296 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

4.03%

Beta

0.56